NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 213 filers reported holding NEOGENOMICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,448,920 | -22.7% | 280,400 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $4,462,639 | -1.0% | 277,700 | +7.3% | 0.00% | 0.0% |
| Q1 2023 | $4,507,449 | +69.1% | 258,900 | -10.3% | 0.00% | +50.0% |
| Q4 2022 | $2,665,740 | +10.2% | 288,500 | +2.7% | 0.00% | 0.0% |
| Q3 2022 | $2,419,000 | +7.4% | 281,000 | +1.6% | 0.00% | 0.0% |
| Q2 2022 | $2,253,000 | -32.9% | 276,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,359,000 | -61.7% | 276,500 | +7.7% | 0.00% | -60.0% |
| Q4 2021 | $8,762,000 | -26.6% | 256,800 | +3.7% | 0.01% | -37.5% |
| Q3 2021 | $11,944,000 | +8.0% | 247,600 | +1.1% | 0.01% | +14.3% |
| Q2 2021 | $11,062,000 | -4.8% | 244,900 | +1.6% | 0.01% | -12.5% |
| Q1 2021 | $11,623,000 | -9.0% | 241,000 | +1.6% | 0.01% | -11.1% |
| Q4 2020 | $12,771,000 | +46.5% | 237,200 | +0.4% | 0.01% | +28.6% |
| Q3 2020 | $8,717,000 | +27.1% | 236,300 | +6.7% | 0.01% | +16.7% |
| Q2 2020 | $6,859,000 | +29.1% | 221,400 | +15.1% | 0.01% | 0.0% |
| Q1 2020 | $5,312,000 | -3.9% | 192,400 | +1.9% | 0.01% | 0.0% |
| Q4 2019 | $5,525,000 | +57.8% | 188,900 | +3.2% | 0.01% | +50.0% |
| Q3 2019 | $3,501,000 | -4.6% | 183,100 | +9.5% | 0.00% | 0.0% |
| Q2 2019 | $3,668,000 | +9.7% | 167,200 | +2.3% | 0.00% | 0.0% |
| Q1 2019 | $3,345,000 | +66.5% | 163,500 | +2.6% | 0.00% | +33.3% |
| Q4 2018 | $2,009,000 | +3.9% | 159,300 | +26.4% | 0.00% | +50.0% |
| Q3 2018 | $1,934,000 | +42.1% | 126,000 | +21.4% | 0.00% | 0.0% |
| Q2 2018 | $1,361,000 | +60.7% | 103,800 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $847,000 | -2.5% | 103,800 | +5.8% | 0.00% | 0.0% |
| Q4 2017 | $869,000 | -20.4% | 98,100 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,092,000 | +24.2% | 98,100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $879,000 | -8.4% | 98,100 | -19.4% | 0.00% | 0.0% |
| Q1 2017 | $960,000 | -8.0% | 121,700 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $1,043,000 | +12.6% | 121,700 | +8.0% | 0.00% | +100.0% |
| Q3 2016 | $926,000 | +20.7% | 112,700 | +18.1% | 0.00% | 0.0% |
| Q2 2016 | $767,000 | – | 95,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |